VARIATION IN USE OF REPURPOSED MEDICATIONS AMONG PATIENTS WITH COVID-19
Critical Care Medicine
; 50:83-83, 2022.
Article
in English
| Academic Search Complete | ID: covidwho-1593486
ABSTRACT
Repurposed medications, including antivirals, corticosteroids, hydroxychloroquine, immunomodulators and therapeutic dose anticoagulants were evaluated using multivariable adjusted random effects logistic regression models and unsupervised clustering. B Results:
b Among 7069 adults hospitalized with COVID-19, 1979 (28%) received antivirals, 2876 (41%) received corticosteroids, 1779 (25%) received hydroxychloroquine, 620 (9%) received immunomodulators and 2154 (31%) received therapeutic dose anticoagulants. Contribution of hospital site to risk-adjusted variation was 46% for antivirals, 30% for corticosteroids, 48% for hydroxychloroquine, 46% for immunomodulators, and 19% for therapeutic dose anticoagulants. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
Full text:
Available
Collection:
Databases of international organizations
Database:
Academic Search Complete
Language:
English
Journal:
Critical Care Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS